12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several healthcare stocks experienced significant movements. Myomo, Cellectar Biosciences, Avalo Therapeutics, Shattuck Labs, Connect Biopharma Hldgs, and Synaptogenix saw their stocks rise by 20.1%, 18.72%, 17.56%, 16.99%, 16.54%, and 15.47% respectively. On the other hand, Morphic Holding, VolitionRX, Pharming, Applied Molecular, Seelos Therapeutics, and T2 Biosystems saw their stocks decrease by 27.1%, 24.92%, 19.31%, 16.72%, 15.32%, and 14.19% respectively.
September 22, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cellectar Biosciences' stock rose by 18.72% during Friday's session, with a trading volume of 168.2K, which is 27.8% of its average full-day volume over the last 100 days. The company's market cap is $25.3 million.
The significant increase in Cellectar Biosciences' stock price, coupled with a relatively high trading volume, indicates positive investor sentiment. This could potentially lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Myomo's stock rose by 20.1% during Friday's session, with a trading volume of 192.5K, which is 35.6% of its average full-day volume over the last 100 days. The company's market cap is $33.1 million.
The significant increase in Myomo's stock price, coupled with a relatively high trading volume, indicates positive investor sentiment. This could potentially lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Morphic Holding's stock decreased by 27.1% during Friday's session, with a trading volume of 3.7 million, which is 961.7% of its average full-day volume over the last 100 days. The company's market cap is $1.7 billion.
The significant decrease in Morphic Holding's stock price, coupled with a very high trading volume, indicates negative investor sentiment. This could potentially lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
VolitionRX's stock decreased by 24.92% during Friday's session, with a trading volume of 1.2 million, which is 970.0% of its average full-day volume over the last 100 days. The company's market cap is $59.8 million.
The significant decrease in VolitionRX's stock price, coupled with a very high trading volume, indicates negative investor sentiment. This could potentially lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100